Use of a ventricular septal defect occluder for apical closure in transapical aortic valve replacement.

Détails

ID Serval
serval:BIB_07EDA7E358FB
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Use of a ventricular septal defect occluder for apical closure in transapical aortic valve replacement.
Périodique
Innovations
Auteur(s)
Ferrari E., Locca D., Berdajs D., Marcucci C., Gronchi F., Lavanchy J., Prêtre R., Tozzi P.
ISSN
1559-0879 (Electronic)
ISSN-L
1556-9845
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
10
Numéro
1
Pages
68-70
Langue
anglais
Résumé
During transapical transcatheter aortic valve replacement (TA-TAVR), the apical closure remains a challenge for the surgeon, having the risk for ventricular tear and massive bleeding. Apical closure devices are already under clinical evaluation, but only a few can lead to a full percutaneous TA-TAVR. We describe the successful use of a 9-mm myocardial occluder (ventricular septal defect occluder) that was used to seal the apex after a standard TA-TAVR (using the Sapien XT 23-mm transcatheter valve and the Ascendra + delivery system). The placement of the nonmodified myocardial occluder was performed through the Ascendra + delivery system, with a very small amount of blood loss and an acceptable sealing of the apical tear. This approach is feasible and represents a further step toward true-percutaneous transapical heart valve procedures. Modified apical occluders are under evaluation in animal models.
Pubmed
Création de la notice
26/05/2015 11:49
Dernière modification de la notice
20/08/2019 13:30
Données d'usage